Free Trial

Two $6B Launces: HSBC 3-part and...........>

PIPELINE
PIPELINE: Two $6B Launces: HSBC 3-part and GlaxoSmithKline 5-part
Date $MM Issuer/Rating/Desc/Maturity/Yld/Leads; Priced *; Launch #:
05/10 $400M *Southern California Fas WNG 30Y +100
05/10 $6B #HSBC $2B 3NC2 FRN +60, $2B 6NC5 +112, $2B 6NC5 +100
05/10 $6B #GlaxoSmithKline 5-part:
      $1.25B 3Y fix +55 $750M 3Y FRN +35, 
      $1.25B 5Y +65, $1B 7Y +80, $1.75B 10Y +90
05/10 $Benchmark ANZ 3Y fix +70a, 3Y FRN L equiv

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.